Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma

Osteosarcoma affects about 2.8% of dogs with cancer, with a one-year survival rate of approximately 45%. The purpose of this study was to characterize mutation and expression profiles of osteosarcoma and its association with outcome in dogs. The number of somatic variants identified across 26 sample...

Descripción completa

Detalles Bibliográficos
Autores principales: Das, Sunetra, Idate, Rupa, Regan, Daniel P., Fowles, Jared S., Lana, Susan E., Thamm, Douglas H., Gustafson, Daniel L., Duval, Dawn L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505454/
https://www.ncbi.nlm.nih.gov/pubmed/34635775
http://dx.doi.org/10.1038/s42003-021-02683-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505454/
https://www.ncbi.nlm.nih.gov/pubmed/34635775
http://dx.doi.org/10.1038/s42003-021-02683-0

Ejemplares similares